CLINICAL_TRIALS
trial_result
· 2017-01-18
Clinical Trial Update: BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial results for BMS-188667 in children and adolescents with juvenile idiopathic arthritis have been completed and are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Juvenile Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-01-18